We should see some analyst upgrades from here |
Looks like a solid buy all the way up to the H1 financials late July to me, then the target net debt/EBITDA multiple will trigger release of shareholders returns..
06.12.2023 gap down filled... :o) |
Very pleasing :-) |
Almost at £25. Perhaps the US market will take it higher. My last buy was 2835p in April 2023 so further to go for me |
All looks good divi up debt coming down this may be the turning point for the share price. |
SYME IS NOW READY TO FLY |
Think gaps are/have been filled ??
purely academic ? question on my part . |
blippy3 That would be bn not m (unfortunately!) |
BATS reported a net loss after impairment , Net Debt reduced and div increased, result therefore is decent and that ‘s why share price shot io over £1 |
@Steven Adjusted net debt down 11% to £33.9m. |
58.88p dividend every 13 weeks, I like it. That will look good when interest rates start falling later this year, well even superb now, I suppose, lol, |
@steve adjusted EBITDA down to 2.6x
Salty. |
Anyone knows what is the debt after today result , nothing was mentioned on this except increasing yearly dividend by 2% .
Can someone here tell me , has BATS debt reduces or increases .? The least qtr result , debt went up .
Is it BATS just telling us (the shareholders) the good news only but not the bad news. |
@tufty - the price of the stock has been hammered in the last year and it was a combination of ESG policies in the major investment houses and negative sentiment around NPG. Today’s numbers prove the BATS is miles ahead of schedule on NPG. Brokers are gonna have to look forward now into a future where the ESG issues are diminished and that’s why I think there will be a significant re-rate for this company. I think IMB is dramatically under valued too.
Salty. |
I had hoped the markets would sell this off in the morning, until the reality of this good update became apparent. Sadly, my buy order never came close to hitting, but ultimately, I am just pleased that the news was positive :) GLA. |
Decent results, especially new categories.
"BAT seeking to monetise some of its stake in ITC, which it has held since the early 1900s. The Indian conglomerate fell 3.1% on the news…"
I suppose a trimming of ITC stake was inevitable. |
For once I am in agreement with Monty - superb results and the lovely divs will continue. One of my core holdings, thank goodness. If only I had more of these and a few less BT. |
Very strong results,only fly in the ointment is non- cash impairments charges. |
I sea short position over 7m shares in US Bats adrs, good luck bears buying back to close. |
#Montyhedge.., ahead of forecast, mid range is clearly 2.5, and that should be post H1-2024 then buybacks or a special..?
06.12.2023 - We are making progress towards reaching the middle of our guided 2-3x adjusted net debt / adjusted EBITDA leverage range and expect to be around 2.7x by year end..
08.02.2024 - operating cash flow conversion 100% - organic adjusted net debt / adjusted EBITDA down to 2.6x |
Was priced for the worst.
Results very very strong.
Buyback in H2 will push this back to £35+ in 2025! |
What a difference a day makes. |
You wait until buybacks return, when debt comes down, then I reckon back over 3000p. In the meantime just keep taking this superb 235.52p dividend. |
- Reported loss from operations of £15,751m (with reported operating margin down 95.8 ppts to -57.7%) - impacted by a £27.6 billion non-cash impairment charge mainly related to our U.S. business (£27.3 billion) |
Salty, where would you put the re rate at?
I agree today makes for good reading and I hope this is a trigger point for a push towards 3000 again eventually. We were there this time last year so I don't think that's too unrealistic but with UK listed companies then who knows these days.
Good luck all 👍🏻 |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
